The purpose of the Western Regional Center for Biodefense and Emerging Infectious Disease Research (WRCE) Developmental Research program is to provide overall guidance required to solicit, evaluate, select, and manage pilot research projects that are critical to the development and sustainability of a productive basic and applied biodefense research program. The program will function as an integral component of the WRCE's mission by expanding the scope of research, increasing the pool of biodefense researchers and the number of institutions involved in the WRCE, opening up new lines of research and developing new technologies needed to contribute to the development of mission-relevant countermeasures. The Developmental Research plan takes advantage of the region's wealth of relevant scientific expertise by identifying and promoting new research ideas, and employing and developing novel technologies. The research projects will be conducted by established biodefense and emerging infectious disease investigators, and by researchers new to the field, who are willing to apply their expertise to conduct a novel aspect of product-oriented research. A systematic and rigorous administrative and scientific management plan, similar to the plan used during the first WRCE grant cycle, will be employed to allow for the selection of the most relevant and scientifically sound research projects, and for effective monitoring and evaluation of progress. The WRCE Director will have overall responsibility for the Developmental Research program and will designate the WRCE Associate Director to manage the plan. The Associate Director will be supported by the WRCE Program Administrator, other key WRCE Administrative Core personnel, and the WRCE Research Project Theme Leaders. In addition, the WRCE Associate Director for Product Development and the WRCE Steering Committee will be called upon as needed when decisions are made regarding continued support for productive projects, the redirection of projects, or the discontinuation of unproductive projects. Also, the selection of new projects will rely upon the scientific expertise of the Steering Committee, the WRCE Director, and the NIAID program officers. This expertise, working in concert, contributes to the establishment and sustainability of productive Developmental Research projects within the WRCE.

Public Health Relevance

The WRCE Developmental Research program takes advantage of emergent technology and new research opportunities to support NIAID's efforts to support multifaceted research to provide scientific information and translational research capacity that will facilitate the next generation of therapeutics, diagnostics, and vaccines against the NIAID Category A-C Priority Pathogens and Emerging and Re-emerging Disease Agents.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-DDS-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Medical Br Galveston
United States
Zip Code
Paterson, Andrew S; Raja, Balakrishnan; Garvey, Gavin et al. (2014) Persistent luminescence strontium aluminate nanoparticles as reporters in lateral flow assays. Anal Chem 86:9481-8
Santiago, Felix W; Covaleda, Lina M; Sanchez-Aparicio, Maria T et al. (2014) Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J Virol 88:4572-85
Pflughoeft, Kathryn J; Swick, Michelle C; Engler, David A et al. (2014) Modulation of the Bacillus anthracis secretome by the immune inhibitor A1 protease. J Bacteriol 196:424-35
Lavinder, Jason J; Wine, Yariv; Giesecke, Claudia et al. (2014) Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc Natl Acad Sci U S A 111:2259-64
Valbuena, Gustavo; Halliday, Hailey; Borisevich, Viktoriya et al. (2014) A human lung xenograft mouse model of Nipah virus infection. PLoS Pathog 10:e1004063
Nieves, Wildaliz; Petersen, Hailey; Judy, Barbara M et al. (2014) A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis. Clin Vaccine Immunol 21:747-54
Gardner, Christina L; Hritz, Jozef; Sun, Chengqun et al. (2014) Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design. PLoS Negl Trop Dis 8:e2719
Litvinov, Julia; Hagström, Anna E V; Lopez, Yubitza et al. (2014) Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation. Biotechnol Lett 36:1863-8
Caro-Gomez, Erika; Gazi, Michal; Goez, Yenny et al. (2014) Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approach. Vaccine 32:4968-76
Georgiou, George; Ippolito, Gregory C; Beausang, John et al. (2014) The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat Biotechnol 32:158-68

Showing the most recent 10 out of 303 publications